- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03221829
A Retrospective Analysis of Spinal Anaesthesia for TURBT Procedures in Elderly Patients
July 14, 2017 updated by: Karolina Dobrońska, Medical University of Warsaw
A Retrospective Analysis of Spinal Anaesthesia for Transurethral Resection of Bladder Tumour in Elderly Patients: A Single Centre Experience From 2007 to 2017
The aim of the study was to evaluate the safety and effectiveness of spinal anesthesia among elderly patients The basic methods for diagnosis and management of bladder cancer include endoscopic procedures (cystoscopy, trans-urethral resection of bladder tumour TURBT).
The age of most patients is above 60, which increases the risk of complications during the perioperative period.
Usually the leading anaesthesia method in TURBT procedures is regional, mainly spinal, anaesthesia.
Although the prevalence of regional upon general anaesthesia is questioned, certain positive aspects of regional anaesthesia are indisputable.
Maintaining logical communication with a patient during the procedure enables early diagnosis of complications (TUR syndrome, bladder perforation).
Undeniably, regional anaesthesia ensures the best pain management in the early post-operative period.
The simplicity of performing an efficacious spinal block and its cost-effectiveness are additional factors, which have contributed to the acknowledgement of the method as the standard of anaesthesia for transurethral procedures.
Study Overview
Status
Unknown
Study Type
Observational
Enrollment (Anticipated)
2800
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Warsaw, Poland, 02-005
- Recruiting
- I Department of Anaesthesiology and Intensive Care, Medical University of Warsaw
-
Contact:
- Karolina Dobronska, MD
- Phone Number: +48 22 501 17 27
- Email: karolinapladzyk@gmail.com
-
Contact:
- Lidia I Jureczko, PhD MD
- Phone Number: +48 22 501 17 27
- Email: jureczko@gmail.com
-
Principal Investigator:
- Karolina Dobronska, MD
-
Sub-Investigator:
- Lidia I Jureczko, PhD MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patients that have TURBT procedure under spinal anaesthesia in the Urology Departament (Medical University of Warsaw) 2007-2017
Description
Inclusion Criteria:
- TURBT procedure
- spinal anaesthesia
- age over 60
Exclusion Criteria:
- general anaesthesia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The effectiveness of spinal anaesthesia for TURBT evaluated by a number of participants that had the procedure done, without the need of conversion to general anaesthesia .
Time Frame: 6 months
|
The investigator evaluates whether the procedure could be completely performed under spinal anesthesia
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The influence of the bupivacaine spinal dose on bradycardia evaluated by a heart rate measurements
Time Frame: 6 months
|
The investigator evaluates the bupivacaine doses, heart rate and the need to give atropine
|
6 months
|
|
The influence of the bupivacaine dose on hypotension evaluated by the non-invasive blood pressure measurements
Time Frame: 6 months
|
The investigator evaluates the bupivacaine doses, blood pressure and the need to give ephedrine
|
6 months
|
|
Experienced and non-experienced anesthetist does it influence the bupivacaine dose
Time Frame: 6 months
|
The investigator evaluates the doses of bupivacaine spinal given by specialist, young and advanced trainee.
|
6 months
|
|
Experienced and non-experienced anesthetist does it influence the spinal anaesthesia success
Time Frame: 6 months
|
The investigator evaluates the success rate of spinal anaesthesia given by specialist, young and advanced trainee.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 6, 2017
Primary Completion (Anticipated)
December 31, 2017
Study Completion (Anticipated)
December 31, 2017
Study Registration Dates
First Submitted
July 13, 2017
First Submitted That Met QC Criteria
July 14, 2017
First Posted (Actual)
July 19, 2017
Study Record Updates
Last Update Posted (Actual)
July 19, 2017
Last Update Submitted That Met QC Criteria
July 14, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- U/2/2017
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bladder Tumor
-
Seoul National University HospitalUnknownProstate Cancer | Bladder Cancer | Bladder Tumor | Prostate Tumor
-
Taris Biomedical LLCBristol-Myers SquibbTerminatedBladder Cancer TNM Staging Primary Tumor (T) T2 | Bladder Cancer TNM Staging Primary Tumor (T) T2A | Bladder Cancer TNM Staging Primary Tumor (T) T2B | Bladder Cancer TNM Staging Primary Tumor (T) T3 | Bladder Cancer TNM Staging Primary Tumor (T) T3A | Bladder Cancer TNM Staging Primary Tumor... and other conditionsUnited States
-
University of Rome Tor VergataUniversity Of Perugia; University of L'AquilaCompletedBladder Cancer TNM Staging Primary Tumor (T) Ta | Bladder Cancer TNM Staging Primary Tumor (T) T1 | Bladder Cancer Transitional Cell GradeItaly
-
Ikena OncologyBristol-Myers SquibbCompletedNeoplasms | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Bladder Cancer | Advanced Solid Tumor | Advanced Cancer | Urothelial Carcinoma Bladder | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | Bladder Disease | Solid Carcinoma | Neoplasm Malignant | Neoplasm, Bladder | Locally Advanced... and other conditionsUnited States
-
Careggi HospitalCompleted
-
UroSee CorporationUnknownBladder TumorUnited States
-
Case Comprehensive Cancer CenterWithdrawnNon-muscle Invasive Bladder Cancer (NMIBC) | Bladder Tumor (TURBT)United States
-
Chinese University of Hong KongUnknownUrinary Bladder TumorHong Kong
-
H. Lee Moffitt Cancer Center and Research InstituteJohns Hopkins University; National Institutes of Health (NIH)WithdrawnBladder Cancer | Urothelial Carcinoma | Bladder TumorUnited States